Chemical-structure (Imatinib Molecule)
Imatinib Mesylate Tablet, Film Coated
Product Images NDC 0904-6621
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 0904-6621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Figure 1)
Figure-2 (Figure 2)
The text provided is a table with some data points related to patients and their treatment with drugs called Imatinib Mesylate, IFN4ARAC. The table presents different numbers, including the number of patients with progression of AP or BC and those censored at discontinuation, as well as a ratio, a Log-rank Test, and the time frame in months. The meaning and context of this table are not clear, so no further details can be provided.*
Carton Label (Image 01)
This text is describing a medication called Imatinib Mesylate, which comes in tablet form. The tablet is 1 mg and is only available with a prescription. The label lists the National Drug Code (NDC) as 0904-6901-04 and provides information about the dosage, precautions, and storage of the medication. The tablet is produced by a company called Major and is distributed by Argv. There is also a lot number listed, but no other information is available.*
Carton Label (Image 02)
This is a description of a medication called Imatinib Mesylate, which comes in tablet form. The National Drug Code (NDC) for this medication is 0904-6621-04 and it is only available with a prescription. Each bottle contains 470 mg of the medication, which is equivalent to 530 mg of it according to the text. The dosage information should be obtained from the prescription and precautions must be taken while storing the medication. The medication must be kept away from children and should not be used without following the prescription. The packaging appears to be designed for use in a hospital or clinical setting. The manufacturer appears to be MAJOR RENACR TICALS.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
